↓ Skip to main content
What is this page? Embed badge

First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial

Overview of attention for article published in Blood, April 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

policy
1 policy source
twitter
1 X user
patent
3 patents
wikipedia
1 Wikipedia page

Readers on

mendeley
86 Mendeley
connotea
1 Connotea
So far, Altmetric has seen 1 policy document that references this research output.
This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.